most evidence is preclinical and observational
You might think that would at least coincide with a superior safety profile, but that same study saw a greater rate of trial discontinuation due to adverse effects in the liraglutide group than in the semaglutide group.7 It also requires daily dosing, which is less convenient than the weekly administration of semaglutide and tirzepatide
Research protocols use 0.1-0.3 mg per dose, administered subcutaneously in the evening
L-carnitine is also essential for normal heart function and L- carnitine supplementation is recommended for parties with heart failure
Your body uses glutathione to "clean up" cellular waste, so the more waste there is, the more glutathione you may need
Sources FDA Prescribing Information: Zepbound (tirzepatide) January 2026 label New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) AJMC: FDA Approves Monthly KwikPen Option for Tirzepatide Drugs.com: Tirzepatide (Zepbound) dosing and safety Eli Lilly: Mounjaro Prescribing Information Medical disclaimer This article is for educational purposes only and does not constitute medical advice
